相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis
Aigerim Abdrakhman et al.
ANTIVIRAL RESEARCH (2021)
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
Michel Bazinet et al.
HEPATOLOGY COMMUNICATIONS (2021)
Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia
Adriana Palom et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
Zhijiang Miao et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D
Ben L. Da et al.
ANTIVIRAL RESEARCH (2020)
High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort
Jan-Hendrik Bockmann et al.
BMC GASTROENTEROLOGY (2020)
Treatment of hepatitis D: an unmet medical need
G. P. Caviglia et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1
Michelle Spaan et al.
JOURNAL OF HEPATOLOGY (2020)
Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Dulce Alfaiate et al.
JOURNAL OF HEPATOLOGY (2020)
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Alexander J. Stockdale et al.
JOURNAL OF HEPATOLOGY (2020)
HDVdb: A Comprehensive Hepatitis D Virus Database
Zainab Usman et al.
VIRUSES-BASEL (2020)
Hepatitis Delta Prevalence, Natural History, and Treatment Options
Julian Hercun et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)
Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection
Nicole D. Ferrante et al.
CURRENT HIV/AIDS REPORTS (2020)
The Severity of Hepatitis D in Young Adults of Age 18-25 Years
Zaigham Abbas et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Hai-Yan Chen et al.
GUT (2019)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer et al.
LANCET INFECTIOUS DISEASES (2019)
A review on hepatitis D: From virology to new therapies
Nathalie Mentha et al.
JOURNAL OF ADVANCED RESEARCH (2019)
Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells
Matthieu Blanchet et al.
ANTIVIRAL RESEARCH (2019)
Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
Heiner Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2019)
Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
Jimena Perez-Vargas et al.
NATURE COMMUNICATIONS (2019)
Chronic hepatitis delta: A state-of-the-art review and new therapies
Christy Gilman et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Concept of Viral Inhibitors via NTCP
Kento Fukano et al.
SEMINARS IN LIVER DISEASE (2019)
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir
Giuseppina Brancaccio et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
Cihan Yurdaydin et al.
HEPATOLOGY (2018)
Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2018)
Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease
Cihan Yurdaydin et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Hepatitis D Viremia Among Injection Drug Users in San Francisco
Parag Mahale et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Antiviral Treatment and Liver- Related Complications in Hepatitis Delta
Anika Wranke et al.
HEPATOLOGY (2017)
Hepatitis delta infection in Italian patients: towards the end of the story?
Tommaso Stroffolini et al.
INFECTION (2017)
Non-invasive fibrosis score for hepatitis delta
Gunnar L. Lutterkort et al.
LIVER INTERNATIONAL (2017)
Genetic Diversity and Worldwide Distribution of the Deltavirus Genus: A Study of 2,152 Clinical Strains
Frederic Le Gal et al.
HEPATOLOGY (2017)
Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population
Fei Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis - end of study results from the LOWR HDV-3 study
C. Koh et al.
JOURNAL OF HEPATOLOGY (2017)
A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
H. Wedemeyer et al.
JOURNAL OF HEPATOLOGY (2017)
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis-end of treatment results from the LOWR HDV-2 study
C. Yurdaydin et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Hepatitis delta: virological and clinical aspects
Luan Felipo Botelho-Souza et al.
VIROLOGY JOURNAL (2017)
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
Michel Bazinet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response
G. A. Niro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
Andrew Vaillant
ANTIVIRAL RESEARCH (2016)
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank et al.
JOURNAL OF HEPATOLOGY (2016)
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
Pavel Bogomolov et al.
JOURNAL OF HEPATOLOGY (2016)
The hepatitis delta virus: Replication and pathogenesis
Camille Sureau et al.
JOURNAL OF HEPATOLOGY (2016)
The adventure of delta
Mario Rizzetto
LIVER INTERNATIONAL (2016)
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Florian A. Lempp et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
Onur Keskin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Pegylated Interferon Therapy of Chronic Hepatitis D: In Need of Revision
Mario Rizzetto et al.
HEPATOLOGY (2015)
Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program
Hsi-Hsun Lin et al.
HEPATOLOGY (2015)
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice
Davor Slijepcevic et al.
HEPATOLOGY (2015)
Hepatitis delta virus infection in Romania: prevalence and risk factors
Journal of Gastrointestinal and Liver Diseases (2015)
Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes
Tatyana Kushner et al.
JOURNAL OF HEPATOLOGY (2015)
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Christopher Koh et al.
LANCET INFECTIOUS DISEASES (2015)
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
Faseeha Noordeen et al.
PLOS ONE (2015)
Management of hepatitis delta: Need for novel therapeutic options
Zaigham Abbas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Analysis on the Clinical Features of 507 HDV-Infected Patients
Xiao-hong Gu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
Benjamin Heidrich et al.
HEPATOLOGY (2014)
Increasing prevalence of HDV/HBV infection over 15 years in France
Annabelle Servant-Delmas et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide
Huan Yan et al.
JOURNAL OF VIROLOGY (2014)
Hepatitis Delta: The Rediscovery
Mario Rizzetto et al.
CLINICS IN LIVER DISEASE (2013)
Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study
Emanuel K. Manesis et al.
JOURNAL OF HEPATOLOGY (2013)
Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D
A. Katsoulidou et al.
JOURNAL OF VIRAL HEPATITIS (2013)
A Population-Based Study of Hepatitis D Virus as Potential Risk Factor for Hepatocellular Carcinoma
Jianguang Ji et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Clinical Features of Hepatitis D
Patrizia Farci et al.
SEMINARS IN LIVER DISEASE (2012)
Hepatitis Delta Virus Diagnosis
Antonella Olivero et al.
SEMINARS IN LIVER DISEASE (2012)
Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
M. Buti et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Outcome of chronic delta hepatitis in Italy: A long-term cohort study
Grazia Anna Niro et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis D virus
Hsuan Hui Shih et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis D virus infection - Not a vanishing disease in Europe!
Heiner Wedemeyer et al.
HEPATOLOGY (2007)
Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients
Chien-Wei Su et al.
GASTROENTEROLOGY (2006)
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study
GA Niro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Chronic hepatitis D: A vanishing disease? An Italian multicenter study
GB Gaeta et al.
HEPATOLOGY (2000)
分享论文
